000 05126nam a2200709 i 4500
001 20163402692
003 CtWfDGI
005 20201201155128.0
006 m o d
007 cr zn||||uuuuu
008 170403t20172017enkad ob 000 0 eng d
020 _z9781780644394
_q(alk. paper)
040 _aCtWfDGI
_beng
_erda
_cCtWfDGI
050 1 4 _aRM267
_b.A57 2017eb
082 0 4 _a615.7/922
_223
245 0 0 _aAntimicrobial stewardship :
_bprinciples and practice /
_cedited by Kerry L. LaPlante, PharmD, FCCP, Cheston B. Cunha, MD, Haley J. Morrill, PharmD, Louis B. Rice, MD and Eleftherios Mylonakis, MD, PhD, FIDSA.
264 1 _aWallingford, Oxfordshire, UK :
_bCABI,
_c2017.
264 4 _c�2017
300 _a1 online resource (xvii, 431 pages) :
_billustrations, charts
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
520 3 _aThis book is a joint effort led by five editors, Kerry L. LaPlante, Cheston B. Cunha, Haley J. Morrill, Louis B. Rice, and Eleftherios Mylonakis, with a team of section editors and the authors, who have brought together 38 chapters that describe the principles and practice of antimicrobial stewardship, mainly with reference to the US. There are eight sections. The first provides an overview of antibiotic stewardship, and it looks at the principles and history of, clinical perspectives on, and importance of education in antimicrobial stewardship. The second, on the principles of antibiotic resistance in antibiotic stewardship, covers the mechanisms of antibiotic resistance, the roles of selection, induction, and colonization in its emergence, and its association with antibiotic usage strategies. Section III, on the role of the microbiology laboratory, considers active surveillance, the antibiogram, selective reporting, and new diagnostics. The fourth section, on infection control, reviews the epidemiology of a number of important antimicrobial-resistant organisms and discusses the role of the hospital epidemiologist in antibiotic stewardship. Section V, on the pharmacokinetic and pharmacodynamic aspects of antibiotic dosing, deals with the principles of pharmacokinetics/pharmacodynamics, the optimal use of several classes of antibiotics, and switching from intravenous to oral dosing. The sixth section, on the role of the pharmacy department, examines the role of pharmacists, formulary management, benchmarking, and stewardship interventions and technologic support for these. Section VII deals with the measurement of outcomes of stewardship programmes, and includes discussion of the guidelines and milestones, economic aspects, adverse events, and stewardship in areas of increased resistance. The final section explores antimicrobial stewardship at different practice sites, looking at how it converges with the unique populations involved.
504 _aIncludes bibliographical references.
505 0 _aOverview of Antibiotic Stewardship -- Principles of Antibiotic Resistance in Antibiotic Stewardship -- Role of the Microbiology Laboratory in Antibiotic Stewardship -- Infection Control Aspects of Antibiotic Stewardship -- Pharmacokinetic and Pharmacodynamic Aspects of Antibiotic Dosing in Antibiotic Stewardship -- Role of the Pharmacy Department in Antibiotic Stewardship -- Measuring Outcomes in Antibiotic Stewardship Programs -- Antimicrobial Stewardship and Various Practice Sites.
506 _aAccess limited to subscribing institution.
530 _aAlso available in print format.
588 _aTitle from PDF title page (viewed April 3, 2017).
650 0 _aAntibiotics.
650 0 _aDrug resistance in microorganisms.
650 1 2 _aAnti-Bacterial Agents
_xadministration & dosage
650 2 2 _aDrug Resistance, Microbial
650 2 2 _aInappropriate Prescribing
_xprevention & control
650 7 _aAntibiotics.
_2cabt
650 7 _aAntiinfective agents.
_2cabt
650 7 _aDiagnosis.
_2cabt
650 7 _aDrug resistance.
_2cabt
650 7 _aDrug therapy.
_2cabt
650 7 _aEconomic analysis.
_2cabt
650 7 _aEducation.
_2cabt
650 7 _aEpidemiology.
_2cabt
650 7 _aGuidelines.
_2cabt
650 7 _aHealth care.
_2cabt
650 7 _aHealth programmes.
_2cabt
650 7 _aHospitals.
_2cabt
650 7 _aHuman diseases.
_2cabt
650 7 _aInfection control.
_2cabt
650 7 _aInfectious diseases.
_2cabt
650 7 _aMicrobiology.
_2cabt
650 7 _aPharmacodynamics.
_2cabt
650 7 _aPharmacokinetics.
_2cabt
650 7 _aPharmacology.
_2cabt
650 7 _aPharmacy.
_2cabt
700 1 _aLaPlante, Kerry,
_eeditor.
700 1 _aCunha, Cheston B.,
_eeditor.
700 1 _aMorrill, Haley J.,
_eeditor.
700 1 _aRice, Louis B.,
_eeditor.
700 1 _aMylonakis, Eleftherios,
_eeditor.
710 2 _aC.A.B. International,
_eissuing body.
776 0 8 _iPrint version:
_tAntimicrobial stewardship.
_dWallingford, Oxfordshire ; Boston, MA : CABI, [2017]
_z9781780644394 (alk. paper)
_w(DLC)2016022765
856 4 0 _uhttps://dx.doi.org/10.1079/9781780644394.0000
_zClick here to access resource
942 _cEB
999 _c312586
_d312586